On 14 Aug 2014 01:36 AM ,Alan Mackenzie <
a...@muc.de> wrote:
> [skipped inaccuracte mischaracterization
> of my post]
Your post about HbA1c being relatively less
important than a detailed analysis of actual
glucose levels as revealed by a CGM, well,
by both measures. I'm doing great. As for
my HbA1c levels being near or even below
what many who don't have any High Glucose
Condition are at, that's outstanding in any
medical or endocrinological viewpoint.
As well-documented, I've not had any severe
lows since January. That's outstanding in any
medical or endocrinological viewpoint, espe-
cially when combined with my low HbA1c levels,
which I expect will still be estimable when
my HbA1c level is next tested on August 21,
and I get the results back on August 28.
As for above 130 events, few and far between
these days. As for my below 55 events, well,
here's my complete what's called a "Success
Report" from the Dexcom program which dis-
plays my CGM levels on a computer:
Since July 28, 2014, 3 days after going on the
low carb diet I'm currently on:
< 55 mg/dl ... 0%
>=55 and < 70 mg/dl ... 8%
>=70 and <= 130 mg/dl ... 87%, with most
of the readings being >=70 and <=99 (64%)
>130 and <= 160 mgl/dl ... 4%
> 160 mg/dl ... 0%
Average glucose level = 92.
By any/every perspective one might come up
with, that's simply outstanding, stats that
should go in the Hall of Fame for those who
have Insulinitis and are forced to guessti-
mate the insulin dosages many times per day
and night (yesterday, for example, I made
24 dosage decisions, 6 involving changes to
basal delivery, 18 involving bolus delivery).
I suspect that the intense effort I put into
dealing with Insulinitis is not doable, and
certainly is not practicable, for anyone who
relies on insulin injections, so that type
of intense management is only practicable
by someone who is using an insulin pump.
As for your request for information on lower
HbA1c levels being tied to higher hypogly-
cemic risks, and also tied to lower long-
term complication risks, those reports have
been widespread for many years, and I've
included links to them on occasion during
my many posting efforts in this newsgroup.
I suspect that your reticence to endorse
my efforts is because of my detailed report-
age of my struggles with severe hypoglycemia
(which, by the way, have been successful, with
only 1 severe low since November of last year)
and because of my endorsement of new names
for each of the High Glucose Conditions.
As I've taken measures to minimize the risks
of severe lows (seeing an endocrinologist,
going on a CGM and later, on an insulin pump,
accepting a slightly higher HbA1c level while
still keeping it very low, and recently, exper-
imenting with a low carb diet (not as low as
suggested by Richard Bernstein, but still,
qualifying as low carb by the < 126 grams of
carbs per day standard mentioned in recent
articles), I would submit that your stance
is in need of a re-do.
As for the word "control", I dileneated in
detail why that word was not an accurate
description of the manner in which Insulin-
itis is currently dealt with using insulin
guesses and all of the other tools we have
at our disposal, but in any case, I will
submit that -if- one wished to use that
word in assessing how one deals with this
condition, I would come as close as possible
to qualifying for that attribution -if- one
does not disqualify someone for that nomen-
clature if one uses terms you rarely hear,
like "insulin guesses" -or- "Insulinitis".
- - - - - - - - - - - - - - - - - - - - -
Excerpts [with inserts, not part of original
article, included in brackets]:
- - -
Hypoglycemia in ... [Insulinitis]
A still unresolved problem in the era of
insulin analogs and pump therapy
http://care.diabetesjournals.org/content/31/Supplement_2/S121.full.pdf+html&keyword=pediatrics-and-hypoglycemia-clinical-significance
- - -
Abstract
The Diabetes Control and Complications Trial
demonstrated that in patients with ... [Insul-
initis], tight metabolic control achieved with
intensive insulin therapy can reduce the risk
of long-term microvascular complications.
However, strict glycemic control carries an
increased risk of severe hypoglycemia.
Recurrent episodes of hypoglycemia, especially
at young ages, can lead to hypoglycemia unaware-
ness, exert adverse effects on neurocognitive
function, and cause significant emotional mor-
bidity in the child and parents.
Although the introduction of the new insulin
analogs ... and the use of continuous subcutan-
eous insulin infusion raised hopes for a solu-
tion to this problem, these modalities have not
been associated with the expected reduction in
hypoglycemic episodes.
The findings suggest that the prevention of hypo-
glycemia in patients with ... [Insulinitis] lies
in biologically controlled insulin secretion, as
in islet transplantation, or the development of
an autonomous closed-loop system [i.e., an arti-
ficial pancreas, also referred to by some as a
bionic pancreas] that efficiently mimics the
action of the pancreatic beta-cells and maintains
blood glucose levels within the desired range.
CSII, continuous subcutaneous insulin infusion
The benefits of intensive management of ... [Insul-
initis] were clearly established with the publica-
tion of the Diabetes Control and Complications
Trial in 1993. [That trial] demonstrated that
tight metabolic control achieved with intensive
insulin therapy is superior to conventional treat-
ment in reducing the risk of long-term microvas-
cular complications.
However, strict glycemic control has been found
to carry an increased risk of severe hypoglycemia,
especially in patients receiving intensified
insulin therapy. Nocturnal hypoglycemia, which
accounts for about half of all severe episodes,
is particularly dangerous because the warning
symptoms are blunted or absent during sleep.
In healthy subjects with an intact counterregu-
latory defense mechanism, the presence of hypo-
glycemia generates autonomic symptoms that alert
the individual. The body responds by suppressing
insulin release and stimulating glucagon release
from the pancreatic islet cells, thereby protec-
ting the brain from glucose deprivation.
By contrast, in patients with ... [Insulinitis],
the circulating insulin concentration depends
on exogenous administration, so that an insulin
suppression response is impossible. With time,
the glucagon response, too, is diminished partly
or entirely. Recurrent blunting of these auto-
nomic processes, even over the short term, leads
to hypoglycemia unawareness, which in turn further
increases the risk of subsequent severe hypogly-
cemic episodes.
...
- - - end excerpts - - -
- - - - - - - - - - - - - - - - - - - - -
- - -